How many acquisitions has Alkermes made so far?

Alkermes has completed 3 acquisitions so far, with an average acquisition amount of $744M.

Which countries does Alkermes usually acquire in?

Alkermes has made acquisitions in 3 countries with the most activity in South Korea and United States.

Which is Alkermes' latest acquisition?

Alkermes's most recent acquisition is Avadel Pharmaceuticals, a Pharma company with proprietary drug delivery tools and drug for narcolepsy, acquired in October 2025.

In which year did Alkermes make the most acquisitions?

Alkermes was most active in 2025, with 1 acquisition completed in that year.

List of 3 Acquisitions by Alkermes (Oct 2026)

Alkermes has made a total of 3 acquisitions. These were completed across South Korea, United States, and Ireland, spanning Neurology, Nanotechnology, Sleep Medicine, Biotechnology, and Pharmaceuticals. Peak activity occurred in 1992, 2019, and 2025, with 1 acquisition in each year. For the 2020 to 2025 period, the average is 0.2 acquisitions per year, with 0 completed in the current calendar year. The most recent acquisition, finalized in October 2025, is Avadel Pharmaceuticals, a Dublin-based pharma company founded in 1990 that specializes in proprietary drug delivery tools and a treatment for narcolepsy.

Here's the year on year acquisition history of Alkermes:

Number of Total Acquisitions

Year	# Acquisitions
2025	1
2019	1
1992	1

View all Acquisitions by Alkermes

Recent acquisitions by Alkermes

Alkermes's most recent acquisition - Avadel Pharmaceuticals is a Pharma company with proprietary drug delivery tools and drug for narcolepsy, founded in 1990 and located in Dublin. Alkermes acquired it in October 2025 for a price of $*****.

Here is the list of all acquisitions by Alkermes sorted by the latest acquisition date: